Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
10.19
-0.35 (-3.32%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Climb Bio Employees
As of December 31, 2025, Climb Bio had 29 total employees, including 28 full-time and 1 part-time employees. The number of employees increased by 11 or 61.11% compared to the previous year. That makes Climb Bio the 37,251st largest employer in the world and 5,193rd in the United States.
Employees
29
Change (1Y)
11
Growth (1Y)
61.11%
Revenue / Employee
n/a
Profits / Employee
-$1,987,034
Market Cap
585.28M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 29 | 11 | 61.11% | 28 | 1 |
| Dec 31, 2024 | 18 | 7 | 63.64% | 17 | 1 |
| Dec 31, 2023 | 11 | -32 | -74.42% | 9 | 2 |
| Dec 31, 2022 | 43 | 12 | 38.71% | 30 | 13 |
| Sep 30, 2022 | 43 | 15 | 53.57% | 43 | 0 |
| Jun 30, 2022 | 41 | 16 | 64.00% | 41 | 0 |
| Mar 31, 2022 | 37 | 15 | 68.18% | 37 | 0 |
| Dec 31, 2021 | 31 | 9 | 40.91% | 19 | 12 |
| Sep 30, 2021 | 28 | - | - | 28 | 0 |
| Jun 30, 2021 | 25 | - | - | 25 | 0 |
| Mar 31, 2021 | 22 | - | - | 13 | 9 |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 625 |
| Ginkgo Bioworks Holdings | 485 |
| Phathom Pharmaceuticals | 371 |
| CorMedix | 191 |
| Olema Pharmaceuticals | 150 |
| Zevra Therapeutics | 61 |
| Candel Therapeutics | 55 |
CLYM News
- 5 hours ago - Climb Bio, Mabworks announce additional Phase 1 data for CLYM116/MIL116 - TheFly
- 5 hours ago - Climb Bio and Mabworks Announce CLYM116/MIL116 Data Demonstrating Deep, Durable APRIL Suppression and ~70% Gd-IgA1 Reduction at ASN Kidney Week 2026 - GlobeNewsWire
- 3 days ago - Climb Bio management to meet virtually with Piper Sandler - TheFly
- 3 days ago - Climb Bio initiated with a Buy at Deutsche Bank - TheFly
- 3 days ago - Climb Bio initiated with a Buy at Deutsche Bank - TheFly
- 21 days ago - Climb Bio to Present New Data at American Society of Nephrology (ASN) Kidney Week 2026 for CLYM116 and Budoprutug - GlobeNewsWire
- 4 weeks ago - Climb Bio added to ‘Analysts Current Favorites’ at Raymond James - TheFly
- 5 weeks ago - Climb Bio Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts